Irreversible enzyme inhibitors. CLX. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines.
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects*; D002279:Carcinoma 256, Walker / Q000201:enzymology; D002473:Cell Wall / Q000378:metabolism*; D055598:Chemical Phenomena; D002621:Chemistry; D046508:Culture Techniques; D005493:Folic Acid Antagonists; D007939:Leukemia L1210 / Q000201:enzymology*; D008099:Liver / Q000201:enzymology; D051379:Mice; D051381:Rats; D014227:Triazines / Q000032:analysis / Q000494:pharmacology* / Q000633:toxicity
D005493:Folic Acid Antagonists; D014227:Triazines